9 I- O! u3 E, k1 X* g- ~1 V 6 c, V. g. Y9 U" E, O6 b6 X9 ]7 o% V5 n+ {. ]7 M" h2 ~8 h
( |9 F, w# s B2 L8 l" B. E2 [6 u# n' v
+ T1 e' h3 y$ c2 c+ d* Q0 w( v! X2 ]% ]
7 S9 p- v( N7 R4 R9 c0 M7 n7 j" H0 R) H W3 x" P
9 [* n1 W' [/ y ?5 z
7 d) Z7 c r* P, T
6 J" k% Y8 g/ l# `( [8 F& O+ C/ U I& f) h
+ o6 o# F, E( ]7 @1 [ S8 B+ H2 ~
, M: s, N7 I F( X/ V
. B+ [7 n2 E" O$ }9 T" U5 U
4 h- R2 t$ O$ p
2 f0 T% K5 [$ D" k- @0 ]
' D0 t/ q+ Q4 q. M2 v0 `+ e
9 `" l* D1 r5 m, S D
" q }( C0 h6 N4 e
+ J8 s4 d% n! W. C4 u; \ 9 Z: ~0 a7 p3 i4 c 5 g7 P( n$ p5 Z) ?% ^% }8 K ( f# e- A' H5 I6 ITentative Session' H3 M! p6 l4 O, c5 i5 E
China Classification and Variable Selection % {, e$ Z: ~) ~4 R$ S2 {
(Chair: Yang Li, Renmin University of China) 1 @& @' j6 k$ L" X/ [9 x9 }/ z Clinical information data mining and application7 j0 C' x9 w( x% \9 O# c
(Chair: Xiuhua Guo, Capital Medical University) ! s3 q& ?8 E& BJapan Missing Data in Clinical Trials: Basic Concepts and Practical Issues in Japan$ C& e5 w r4 j
(Chair: Hideki Suganami, Ph.D. Kowa Co., Ltd., Satoru Fukinbara, Ph.D. Ono Pharmaceutical Co., Ltd.) 0 T1 |+ e6 l' G8 B 1 T: p6 O7 y: @' U Design and conduct of clinical trials for preventing missing data K# F' w3 B7 l" E v v(Speaker: Shiro Tanaka, Ph.D.Kyoto University)4 O- Z& V) ]7 ?2 G$ F0 }8 r' \
Some examples of the treatment of missing data in investigator-initiated clinical trials" _. R; ~7 H% F) G
(Speaker: Yoichi M. Ito, Ph.D.Hokkaido University)( d, B" Z6 E, E0 q
Actual practice of handling of missing data in clinical trials 2 o m/ g4 V. O
(Speaker: Nobushige Matsuoka, Ph.D., Yoichi Ii, Ph.D., Tamotsu Yoshiyama, M.S., Norisuke Kawai, Ph.D. ,Clinical Statistics, Pfizer Japan Inc.), d1 u. Y# M( }. ]
Survey results from JPMA member companies: Current approach for missing data in pivotal registration trials4 [, Y A- F8 M4 y9 ]
(Speaker: Satoru Tsuchiya, M.S. ,Biostatistics group, Data science Dainippon Sumitomo Pharma, Co., Ltd.); u4 Z: I6 K; e/ D
8 O7 @. b- v; ^( R- L
* X8 S' G8 k/ _9 u
& ]$ O* z3 D6 h' X N
% w9 t x# o! p# VKorea. S9 n6 z: b8 j7 H8 P
0 ~: _" |" S0 d % ~0 H! F1 l# n, a+ K# v8 [4 C; M2 p9 h2 {4 v3 V+ a$ `
4 ~, m8 K3 H: d1 P3 u5 o# b% V2 w6 G8 q) Z8 S) a( p, z
" i0 y& y" R6 _; C: d, G4 b# k. {
Korea Selected Topics in Biometrics study Q2 B% j. Z! W. R$ }(Chair:Hyonggin An, Korea University)6 ]3 c+ x/ c" R( M y
Identification of Variant Associated with Disease using Protein Structural Feature-based Prioritization0 q* h* t' K8 G
(Speaker: Tae-Rim Lee,Korea National Open University,Min-Seok Kwon(Seoul National University),Sungho Won(Chung Ang University),Taesung Park(Seoul National University)) 4 t1 N* u" N" o: }6 c$ _( O+ z ) R( M3 O# s6 F: k5 b0 T8 i+ M1 d
Differential Expression Detection in RNA-seq Data with a Small Number of Replicates : m$ I5 K" N& ^4 R(Speaker: Jungsoo Gim(Seoul National University), Taesung Park(Seoul National University))# |/ ^3 X4 K8 R4 K# I* R' x6 { d1 ~
Investigation of Relationship between Influenza Occurrence and Climatic Factors in Three Major Regions in Korea using Time Series Analysis & t4 v6 W. [* ?/ X! T9 m2 H: ^' e0 M8 \1 X(Speaker: Hyonggin An (Korea University College of Medicine)and Sang-A Cho (National Cancer Center in Korea)) * ]) @+ M6 p; y8 u5 ]% b" h# p Chair: Jinheum Kim, University of Suwon 0 c5 Z3 o% l' i/ d: t0 n8 w# N: y Additive Hazard Model with Additive Frailty for Semi-Competing Risks Data (Speaker: Yun-Nam Kim (Severance Hospital Clinical Trials Center), Chung Mo Nam(Yonsei University College of Medicine), Yang-Jin Kim(Sookkmyung Women’s University), and Jinheum Kim(University of Suwon)) - @% \1 [6 R2 m, F2 t3 I. u Variable Selection in Competing-Risks Frailty Models using Penalized H-likelihood 7 Y4 x$ X5 i, ^7 z* {! K, V(Speaker: Do Ha (Daegu Haany University) and Youngjo Lee (Seoul National University)): o& r0 Q+ v9 G. C8 A
Gene-Gene Interaction Analysis with Survival Phenotype0 r0 ~; l. Z3 h K) B- P3 a
(Speaker: Seungyeon Lee (Sejong University), Jin-SeokOh(Sejong University), Min-Seok Kwon(Seoul National University), and Taesung Park(Seoul National University)) 1 Y. X+ D: s) F" u8 m! n Maximally Selected Two-sample Gray Statistics with Competing Risks Data# D! x, Z$ P& L" m2 F6 h
(Speaker: Jinheum Kim (University of Suwon), Sook-young Woo(Samsung Advanced Institute of Technology), Seonwoo Kim(Samsung Advanced Institute of Technology)) . g) B- N- f3 P; v- {& ~, T* WSingapore Session title: Likelihood based inference for complex models) k0 {7 p0 u! q! D1 T1 ~5 E& k- b
A multiple imputation method for longitudinal data with covariate measurement error under generalized partially linear mixed models+ B1 H- _) S! N3 l* l6 H4 S
(Speaker: Xiang Liming(Nanyang Technological University)) ( q. h# H# l$ u6 n6 k( F) x: z Bayesian Empirical Likelihood * q& E. M- M, m! Y6 \' A, u) T, F(Speaker: Sanjay Chaudhuri(National University of Singapore, Singapore)) & K! C: S' @2 I Consistent Cross-Validation for Tuning Parameter Selection in High-Dimensional Variable Selection 6 G0 j) o! `4 y(Speaker: Yang Feng(Columbia University))3 D, ?8 B* G* u+ h3 j; O
A sign based loss approach to model selection in nonparametric regression! Y1 c! a, h _5 ?3 z8 e
(Speaker: Li Jialiang (National University of Singapore, Singapore)) 2 [2 I# b- y, y$ L* ^Thailand Meta analysis in Clinical Trials " n# n. v; B7 g: z. R5 F5 w8 ] Publication Bias and Sensitivity Analysis for Meta-Analysis of Multi-Arm Trials 8 F( y4 Y& _% f(Speaker: Dr. Hathaikan Chootrakool (Suan Dusit Rajabhat University)) 3 O; l9 |9 k% @+ ~( j9 h Some New Tests for Homogeneity of Relative Risks in Meta-Analysis 5 p/ U$ X- J+ h# @3 `+ E, R(Speaker: Assoc. Prof. Dr. Chtwongkasemukiat Viwatwongkasem (Mahidol University))0 @8 x1 j0 n3 x
Application of Network Meta-analysis in Randomized Controlled Trials 0 e/ \3 v/ }" @0 `% \$ p5 }+ Y(Speaker: Dr. Ammarin Thakkinstian(Ramathibodi Hospital, Mahidol University)) ! E+ K/ ]. {& z9 j& H5 a% I5 L' G9 F6 L" u
$ P1 T# {4 C( Q
; z9 w% w! N( g) W, [8 L0 M. a
2 ?* D! Q5 t2 t1 k* z: r+ t, W% F$ U
IP卡
狗仔卡
发表于 2013-6-9 23:09
转播
淘帖
分享
收藏
支持
反对
微信
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
抢沙发
显身卡
